Home > News > Starpharma Honoured with the 2005 Frost & Sullivan Award
August 8th, 2005
Starpharma Honoured with the 2005 Frost & Sullivan Award
Abstract:
Starpharma Holdings Limited today announced that it has received the 2005 Frost & Sullivan Growth Strategy Leadership Award in recognition of the company's development of VivaGel(TM) and other polyvalent dendrimer-based products relating to the world nanobiotechnology market.
Source:
businesswire
Bookmark:
Nanomedicine
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Announcements
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013